In The News Posted March 7, 2019 Share Posted March 7, 2019 BARCELONA, Spain, March 7, 2019 /PRNewswire/ -- SOM Biotech, a clinical-stage drug discovery and development company focused on repurposing drugs for orphan diseases of the Central Nervous System headquartered at the Parc Científic de Barcelona (PCB), has just closed a financing round of... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.